[ Price : $8.95]
FDA sends an alert about safety concerns with the use of Getinge/Maquets VasoView HemoPro Endoscopic Vessel Harvesting Systems.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled Prescription Drug User Fee Program.[ Price : $8.95]
Eyenovia decides to terminate its Phase 3 CHAPERONE study evaluating a drug-device combination of low-dose atropine as a potential...[ Price : $8.95]
FDA approves a Syndax Pharmaceuticals NDA for Revuforj (revumenib), a menin inhibitor for treating relapsed or refractory acute le...[ Price : $8.95]
HHS secretary-nominee Robert F. Kennedy Jr. vows to free the agencies, including FDA, from the smothering cloud of corporate captu...[ Price : $8.95]
FDA accepts for review a Sanofi and Regeneron supplemental BLA resubmission for Dupixent (dupilumab) for treating chronic spontane...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance on nonclinical safety assessments for oligonucleotide drug products.[ Price : $8.95]
FDA approves an Atamyo Therapeutics IND for a Phase 1b/2b clinical trial involving its ATA-200 gene therapy for treating rare form...